|
Jun 6
|
Why Novartis (NVS) is a Top Value Stock for the Long-Term
|
|
May 22
|
Latest 340B ruling delivers blow to providers
|
|
May 21
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 15
|
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
|
|
May 14
|
3 Magnificent Stocks That Are Passive Income Machines
|
|
May 14
|
Q1 2024 Legend Biotech Corp Earnings Call
|
|
May 7
|
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 5
|
Questor: this medical stock is expensive – but worth paying for
|
|
May 5
|
2 Magnificent Dividend Stocks to Hold for the Next Decade
|
|
May 3
|
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
|
|
May 3
|
Why selling to Novartis made sense for Mariana
|
|
May 2
|
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
|
|
May 2
|
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
|
|
May 2
|
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
|
|
May 2
|
The top pharmaceutical companies by R&D expenditure
|
|
May 1
|
CVS stock plunges after earnings numbers one analyst 'did not even believe'
|
|
May 1
|
Novartis Is Tracking Well Above the Industry
|
|
Apr 30
|
Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
|
|
Apr 30
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Apr 29
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|